Article

Bryan Lee, MD, JD, wins Vanguard Ophthalmology Society Scholar Award

A fellow at Minnesota Eye Consultants, Bryan S. Lee, MD, JD, is the first winner of the Vanguard Ophthalmology Society Scholar Award, recognizing anterior segment scholarship.

Minneapolis-Bryan S. Lee, MD, JD, a cornea, glaucoma, and refractive surgery fellow at Minnesota Eye Consultants, is the inaugural recipient of the Vanguard Ophthalmology Society Scholar Award.

The award was established this year to identify and honor a top anterior segment fellow in the United States.

Dr. Lee graduated with honors from Harvard College and Harvard Law School. He attended Washington University School of Medicine in St. Louis on a full merit scholarship and attained Alpha Omega Alpha honor society status. He completed his ophthalmology residency at the Wilmer Eye Institute, Johns Hopkins University, Baltimore. He has written for Ophthalmology Times.

After completing his fellowship, Dr. Lee plans to join the faculty of the University of Washington in Seattle, where he hopes to use his combined MD/JD to bring together clinical practice and the legal environment to shape the health care system. He has a special interest in reducing waste, especially administrative and defensive medicine costs, while simultaneously maintaining quality in clinical care.

The Vanguard Ophthalmology Society, a 501(6) nonprofit organization founded in 2009 to recognize and unite future thought leaders in ophthalmology subspecialties related to the anterior segment, has 25 members representing both academia and private practices across the country and internationally.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.